Palisade Bio, Inc. (PALI)

Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $268.67 million. The enterprise value is $276.87 million.

Market Cap	268.67M
Enterprise Value	276.87M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, before market open.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Palisade Bio has 133.00 million shares outstanding. The number of shares has increased by 326.35% in one year.

Current Share Class	133.00M
Shares Outstanding	133.00M
Shares Change (YoY)	+326.35%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	0.43%
Float	45.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.89
P/TBV Ratio	107.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.13.

Current Ratio	1.62
Quick Ratio	1.37
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,010.67

Financial Efficiency

Return on equity (ROE) is -188.48% and return on invested capital (ROIC) is -113.05%.

Return on Equity (ROE)	-188.48%
Return on Assets (ROA)	-77.59%
Return on Invested Capital (ROIC)	-113.05%
Return on Capital Employed (ROCE)	-449.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.03% in the last 52 weeks. The beta is 1.47, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-40.03%
50-Day Moving Average	1.17
200-Day Moving Average	0.95
Relative Strength Index (RSI)	63.90
Average Volume (20 Days)	10,060,847

Short Selling Information

The latest short interest is 5.92 million, so 4.45% of the outstanding shares have been sold short.

Short Interest	5.92M
Short Previous Month	1.04M
Short % of Shares Out	4.45%
Short % of Float	12.91%
Short Ratio (days to cover)	0.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.13M
Pretax Income	-11.85M
Net Income	-11.85M
EBITDA	-12.13M
EBIT	-12.13M
Earnings Per Share (EPS)	-$3.57

Balance Sheet

The company has $5.43 million in cash and $338,000 in debt, giving a net cash position of $5.09 million or $0.04 per share.

Cash & Cash Equivalents	5.43M
Total Debt	338,000
Net Cash	5.09M
Net Cash Per Share	$0.04
Equity (Book Value)	2.62M
Book Value Per Share	0.55
Working Capital	2.48M

Cash Flow

Operating Cash Flow	-9.66M
Capital Expenditures	n/a
Free Cash Flow	-9.66M
FCF Per Share	-$0.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-326.35%
Shareholder Yield	-326.35%
Earnings Yield	-4.20%
FCF Yield	-3.43%

Analyst Forecast

The average price target for Palisade Bio is $12.00, which is 494.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	494.06%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-36.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	Apr 8, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1